Axa S.A. Kamada LTD Transaction History

Axa S.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$6.3 - $8.46 $176,494 - $237,006	-28,015 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$4.56 - $7.13 $118,145 - $184,731	-25,909 Reduced 48.05%	28,015 $163,000
Q2 2019 Aug 13, 2019	BUY	$5.39 - $6.26 $6,349 - $7,374	1,178 Added 2.23%	53,924 $298,000
Q1 2019 May 14, 2019	BUY	$5.12 - $6.18 $270,059 - $325,970	52,746 New	52,746 $302,000

6.37M

2.2K

63.8K

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $235M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.